Navigation Links
Vitacon Receives FDA 510(k) Clearance and Creates US Presence

MINNEAPOLIS, Nov. 16, 2012 /PRNewswire/ -- Vitacon AS, located in Trondheim, Norway, announces major milestones as it continues to expand its global reach. Vitacon has received FDA clearance on its VitaScan LT USB bladder scanner. Vitacon also announces signing a marketing and distribution partnership with SALUS, the Minneapolis-based life science advisory firm.


Non-invasive bladder scanning has become a valuable diagnostic tool. Measuring bladder volume helps avoid indwelling urethral catheters, a major cause of infection. CAUTI (catheter-associated urinary tract infection) treatment is no longer reimbursed if it happens while a patient is hospitalized, thus a major incentive exists to prevent it. 

VitaScan LT enables real-time bladder volume measurement in hospitals, clinics, and home health. It connects via USB to laptop and tablets, providing nearly limitless storage and data transmission capabilities. VitaScan software utilizes intelligent targeting algorithms enabling personnel with limited training to obtain accurate measurements in seconds.

SALUS was selected by Vitacon to implement a US marketing and distribution strategy. "The selection of SALUS is essential to our growth," says Kristin Waro, CEO of Vitacon. "We found their approach unique as they not only created a thorough strategy, but also have the expertise and distribution connections to execute the plan."

SALUS will be responsible for pre-sales support, logistics, and customer service for a nationwide network of distributors. Spencer Lien, SALUS CEO, says, "Vitacon hit our market perfectly, responding to the need for speed, mobility, and cost-effectiveness. Our research indicates a void in the marketplace and we are confident the respective channels to healthcare providers will be equally impressed."

About Vitacon: 

Vitacon AS was founded in 1985 in Trondheim, Norway. Vitacon develops products to treat incontinence and diagnose bladder dysfunction. Vitacon products are well-known throughout Europe.  The company has moved into diagnostic ultrasound and recently launched the VitaScan series of ultrasound scanners offering flexible and cost-effective solutions in bladder volume measurements.

About SALUS:

Salus Consilium, LLC was founded in 2008 by veteran medtech entrepreneur, Spencer Lien. The firm specializes in advising new medical technology ventures and established companies on growth strategies and technology management. Headquartered in Minnesota's "Medical Alley," SALUS offers a variety of services including business development, regulatory and reimbursement strategies, commercialization plans, intellectual property management, and technology transfer.



SOURCE Salus Consilium, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hiker without Human Heart Receives Heart Transplant 607 Miles Later
2. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
3. Beyond Lucid Technologies Receives Funding From Dalmore Investments
4. MedeAnalytics Receives Leadership Award from Ventana Research
5. STD Med Inc. Receives ANVISA Registration for Class III Medical Devices in Brazil
6. OptiNose Receives Grant to Fund Nose-to-Brain Research in Autism Spectrum Disorders
7. Hyland Softwares R4 ACERT Perinatal Reporting System Receives Meaningful Use Certification
8. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
9. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
10. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
11. Sihuans First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused on ... of various clinical conditions, today announced the closing of ... Depository Shares ( ADSs ), each representing 20 ordinary ... to 3,158,900 ADSs. The ADSs and warrants were issued ...
(Date:11/25/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... Officer Antonius Schuh, Ph.D., is scheduled to present a ... Jaffray Healthcare Conference. th Annual Piper ... in New York on Tuesday, ... will be available for one-on-one meetings during the conference. ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... (PRWEB) , ... November 26, 2015 , ... ... Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and ... Office in Nairobi (UNON) for the opening of the 5th African Network for ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):